RSS-Feed abonnieren
DOI: 10.1055/s-0029-1219946
Enantioenriched Naphthoquinone Mannich Bases by Organocatalyzed Nucleophilic Additions to in situ Formed Imines
Publikationsverlauf
Publikationsdatum:
25. Mai 2010 (online)
Abstract
Organocatalytic nucleophilic addition of 2-hydroxylnaphthaquinone to imines is reported. This new route can be used to produce enantioenriched Mannich bases with excellent yields and moderate enantioselectivities.
Key words
organocatalysis - enantioselective Mannich reaction - 1,4-addition - α-amidosulfone - naphthoquinone
- Supporting Information for this article is available online:
- Supporting Information
- Some late reviews on organocatalysis:
-
1a
Gaunt MJ.Johansson CCC.McNally A.Vo NT. Drug Discovery Today 2007, 12: 8 -
1b
Bertelsen S.Jørgensen KA. Chem. Soc. Rev. 2009, 38: 2178 -
1c
Rios R.Cordova A. Curr. Opin. Drug Discovery Dev. 2009, 12: 824 -
1d
Liu XH.Lin LL.Feng XM. Chem. Commun. 2009, 6145 -
1e
Xu LW.Luo J.Lu YX. Chem. Commun. 2009, 1807 -
1f
Zhang ZG.Schreiner PR. Chem. Soc. Rev. 2009, 38: 1187 -
1g
Connon SJ. Synlett 2009, 354 -
2a
Mase N.Tanaka F.Barbas CF. Angew. Chem. Int. Ed. 2004, 43: 2420 -
2b
Northrup AB.MacMillan DWC. Science 2004, 305: 1752 -
2c
Wang J.Li H.Zu LS.Wang W. Adv. Synth. Catal. 2006, 348: 425 -
2d
Enders D.Seki A. Synlett 2002, 26 -
2e
List B. J. Am. Chem. Soc. 2000, 122: 9336 -
2f
Brochu MP.Brown SP.MacMillan DWC. J. Am. Chem. Soc. 2004, 126: 4108 -
2g
Bertelsen S.Halland SN.Stephan B.Marigo M.Braunton A.Jørgensen KA. Chem. Commun. 2005, 4821 -
2h
Westermann B.Neuhaus C. Angew. Chem. Int. Ed. 2005, 44: 4077 -
2i
Clapham B.Cho CW.Janda KD. J. Org. Chem. 2001, 66: 868 -
3a
Ye J.Dixon DJ.Hynes PS. Chem. Commun. 2005, 4481 -
3b
Chen Y.Tian SK.Deng L. J. Am. Chem. Soc. 2000, 122: 9542 -
4a
Uraguchi D.Terada M. J. Am. Chem. Soc. 2004, 126: 5356 -
4b
Storer RI.Carrera DE.Ni Y.MacMillan DWC. J. Am. Chem. Soc. 2006, 128: 84 -
4c
Rueping M.Sugiono E.Azap C.Theissmann T.Bolte M. Org. Lett. 2005, 7: 3781 -
4d
Akiyama T.Morita H.Itoh J.Fuchibe K. Org. Lett. 2005, 7: 2583 -
4e
Wang J.Li H.Yu X.-H.Zu L.-S.Wang W. Org. Lett. 2005, 7: 4293 -
5a
Yoon TP.Jacobsen EN. Angew. Chem. Int. Ed. 2005, 44: 466 -
5b
Okino T.Nakamura S.Furukawa T.Takemoto Y. Org. Lett. 2004, 6: 625 -
5c
Berkessel A.Cleemann F.Mukherjee S.Müller TN.Lex J. Angew. Chem. Int. Ed. 2005, 44: 807 -
5d
Hoashi Y.Okino T.Takemoto Y. Angew. Chem. Int. Ed. 2005, 44: 4032 -
5e
Okino T.Hoashi Y.Furukawa T.Xu X.Takemoto Y. J. Am. Chem. Soc. 2005, 127: 119 -
5f
Berkessel A.Mukherjee S.Mueller TN.Cleemann F.Roland K.Brandenburg M.Neudoerfl JM.Lex J. Org. Biomol. Chem. 2006, 4: 4319 - 6
Okino T.Hoashi Y.Takemoto Y. J. Am. Chem. Soc. 2003, 125: 12672 - 7
Zhou WM.Liu H.Du DM. Org. Lett. 2008, 10: 2817 - 8
Kamei H.Koide T.Kojima T.Hashimoto Y.Hasegawa M. Cancer Biother. Radiopharm. 1998, 13: 185 -
9a
Kayashima T.Mori M.Yoshida H.Mizushina K.Matsubara K. Cancer Lett. 2009, 278: 34 -
9b
Zhao LM.Xiw TP.He YQ.Xu DF.Li SS. Eur. J. Med. Chem. 2009, 1410 -
10a
Bolognesi ML.Lizzi F.Perozzo R.Brun R.Cavalli A. Bioorg. Med. Chem. Lett. 2008, 18: 2272 -
10b
Baramee A.Coppin A.Mortuaire M.Pelinski L.Tomavo S.Brocard J. Bioorg. Med. Chem. 2006, 14: 1294 - 11
Austin JF.Kim SG.Sinz CJ.Xiao WJ.MacMillan DWC. Proc. Natl. Acad. Sci. U.S.A. 2004, 101: 5482
References and Notes
Under the same set of conditions, an attempt to carry out the reaction with benzaldehyde-derived α-amidosulfone (Cbz protected) and 1 resulted in 90% yield, however, enantioselectivity of the product was only 22%.
13
General Procedure
for Addition of Hydroxynaphthoquinone to in situ Formed Imines
In
a 4 mL process vial α-amidosulfone (0.1 mmol),
2-hydroxy-1,4-naphthoquinone
(1, 0.11 mmol), and catalyst (10 mol%)
were dissolved in solvent (0.5 mL). The reaction was allowed to
stir at r.t. (except where mentioned otherwise) for 24 h. Completion
of the reaction was monitored by TLC after which the reaction mixture
was directly subjected to column chromatography (CH2Cl2-MeOH = 99.5:0.5).
The products were dissolved in freshly distilled THF (4-5
mL), and Et3N (1.1 equiv) was added. After stirring the
reaction mixture at r.t. for 5 min, it was cooled to 0 ˚C
and acetyl chloride (1.2 equiv) was added slowly. The reaction mixture
was stirred at the same temperature for another 30 min after which
the product was filtered and concentrated under reduced pressure. Purification
of the product was done by column chromatog-raphy (n-hexane-EtOAc = 90:10).
The ee values for all the products were determined by HPLC on a
chiral stationary phase [Daicel Chiralpak AD-H, n-hexane-i-PrOH (80:20), flow
rate = 1.0 mL/min, λ = 254
nm].
3-(1-{[(Benzyloxy)carbonyl]amino}hexyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl
Acetate (5a)
Yellow oil; yield 40.8 mg (91%); [α]D
²0 25.5
(c 0.38, CH2Cl2);
ee 65%. ¹H NMR (300 MHz, CDCl3-d): δ = 0.86 (t, J = 6.60 Hz, 3 H), 1.20-1.46
(m, 5 H), 1.60-1.79 (m, 2 H), 1.80-1.97 (m, 1
H), 2.44 (s, 3 H), 4.96-5.20 (m, 3 H), 5.79 (d, J = 9.54 Hz, 1 H), 7.22-7.40
(m, 5 H), 7.66-7.79 (m, 2 H), 8.00-8.14 (m, 2
H). ¹³C NMR (75 MHz, CDCl3-d): δ = 13.9, 20.4,
22.4, 25.8, 31.3, 34.5, 47.8, 66.9, 126.7, 128.1, 128.5, 130.7,
132.0, 134.1, 134.3, 136.3, 136.5, 150.7, 155.8, 167.8, 177.9, 185.1.
ESI-MS: m/z (%) = 472.5
(100) [M + Na]+. t
R(major) = 8.7 min; t
R(minor) = 14.9
min.
3-(1-{[(Benzyloxy)carbonyl]amino}ethyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl
Acetate (5b)
Yellow oil; yield 36.2 mg (92%); [α]D
²0 10.8
(c 0.95, CH2Cl2);
ee 42%. ¹H NMR (300 MHz, CDCl3-d): δ = 1.49 (d, J = 6.95 Hz, 3 H), 2.45 (s,
3 H), 4.86-5.36 (m, 3 H), 5.90 (d, J = 9.51
Hz, 1 H), 7.28-7.42 (m, 5 H), 7.67-7.83 (m, 2 H),
8.08 (m, 2 H). ¹³C NMR (75 MHz, CDCl3-d): δ = 20.4, 20.6,
43.6, 66.9, 126.7, 128.1, 128.5, 130.6, 132.0, 134.1, 134.4, 136.2,
137.1, 150.1, 155.5, 167.9, 178.1, 184.9. ESI-MS: m/z (%) = 416.4
(100) [M + Na]+. t
R(major) = 10.9
min; t
R(minor) = 12.9
min.
3-{1-[(
tert
-Butoxycarbonyl)amino]hexyl}-1,4-dioxo-1,4-dihydronaphthalen-2-yl
Acetate (12)
Yellow oil; yield 27.8 mg (67%); [α]D
²0 7.2
(c 0.41, CH2Cl2); ee
33%. ¹H NMR (300 MHz, CDCl3-d): δ = 0.84 (t, J = 6.80 Hz, 3 H), 1.36 (m,
6 H), 1.40 (s, 9 H), 1.36-1.40 (m, 2 H), 2.42 (s, 3 H),
5.05 (m, 1 H), 5.49 (d, J = 9.57
Hz, 1 H), 7.78 (m, 2 H), 8.08 (m, 2 H). ¹³C
NMR (75 MHz, CDCl3-d): δ = 13.9,
20.4, 22.4, 25.8, 28.3, 30.5, 31.3, 34.8, 47.2, 79.6, 126.7, 130.7,
132.0, 134.0, 134.3, 137.0, 150.6, 155.2, 167.8, 178.1. ESI-MS: m/z (%) = 438.4
(100) [M + Na]+. t
R(major) = 4.7 min; t
R(minor) = 6.0 min.
3-(1-{[(4-Methylphenyl)sulfonyl]amino}hexyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl
Acetate (13)
Yellow oil; yield 41.7 mg (89%); [α]D
²0 -13.7
(c 0.34, CH2Cl2);
ee -31%. ¹H NMR (300 MHz,
CDCl3-d): δ = 0.82-0.92
(m, 3 H), 1.17-1.51 (m, 3 H), 1.55-1.68 (m, 4
H), 1.88 (dt, J = 9.17, 4.59
Hz, 1 H), 1.93 (s, 3 H), 2.43 (s, 3 H), 4.54 (d, J = 7.34
Hz, 1 H), 5.73 (br s, 1 H), 6.86 (d, J = 7.70
Hz, 2 H), 7.55 (d, J = 8.07
Hz, 2 H), 7.67-7.77 (m, 2 H), 7.83-7.91 (m, 1
H), 7.93-8.01 (m, 1 H). ¹³C
NMR (75 MHz, CDCl3-d): δ = 13.9,
20.4, 20.9, 22.3, 25.5, 31.0, 34.8, 50.7, 126.4, 126.6, 127.5, 129.4,
130.3, 131.7, 134.2, 137.1, 143.3, 150.9, 167.5, 176.9. ESI-MS: m/z (%) = 492.3
(100) [M + Na]+. t
R(major) = 11.9
min; t
R(minor) = 16.3
min.